FREE SHIPPING over $40
OVER 9000 FIVE-STAR REVIEWS
5% OFF ALL SUBSCRIPTIONS
100% HAPPINESS GUARANTEE
Analyze Diet
0
Home / Equine Research Bank / Anim Front / Neurologic conditions in the sport horse.
Animal frontiers : the review magazine of animal agriculture2022; 12(3); 37-44; doi: 10.1093/af/vfac036

Neurologic conditions in the sport horse.

Abstract: No abstract available
Get Full Text
Publication Date: 2022-06-14 PubMed ID: 35711509PubMed Central: PMC9197298DOI: 10.1093/af/vfac036Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
LinkedInCopy
  • Journal Article

Cite This Article

APA
Bedenice D, Johnson AL. (2022). Neurologic conditions in the sport horse. Anim Front, 12(3), 37-44. https://doi.org/10.1093/af/vfac036

Publication

Animal frontiers : the review magazine of animal agriculture
ISSN: 2160-6064
NlmUniqueID: 101754918
Country: England
Language: English
Volume: 12
Issue: 3
Pages: 37-44

Researcher Affiliations

Bedenice, Daniela
  • Department of Clinical Sciences, Cummings School of Veterinary Medicine at Tufts University, 200 Westboro Road, North Grafton, MA 01536, USA.
Johnson, Amy L
  • Department of Clinical Studies, School of Veterinary Medicine, University of Pennsylvania, New Bolton Center, 382 W Street Rd, Kennett Square, PA 19348, USA.

References

This article includes 30 references
  1. Animal Health Pharmaceuticals. Freedom of information summary, NADA 141–240. REBALANCE Antiprotozoal Oral Suspension (sulfadiazine and pyrimethamine) for the treatment of horses with equine protozoal myeloencephalitis (EPM) caused by Sarcocystis neurona. 2004.
  2. Bedenice D, Johnson AL. Neurologic Conditions Affecting the Equine Athlete.. Vet Clin North Am Equine Pract 2018 Aug;34(2):277-297.
    doi: 10.1016/j.cveq.2018.04.006pubmed: 30007448google scholar: lookup
  3. Birmingham S, Reed S, Mattoon J, Saville WJ. Qualitative assessment of corticosteroid cervical articular facet injection in symptomatic horses. Equine Vet. Educ. 2010;22:77–82.
    doi: 10.2746/095777309X477852google scholar: lookup
  4. Carr EA, Maher O. Neurologic causes of gait abnormalities in the athletic horse. 2014; In: K. W. Hinchcliff, A. Kaneps, and R. Geor, editors. Equine sports medicine and surgery. 2nd edition. St Louis (MO): Elsevier; p. 503–526.
  5. Dill SG, Correa MT, Erb HN, deLahunta A, Kallfelz FA, Waldron C. Factors associated with the development of equine degenerative myeloencephalopathy.. Am J Vet Res 1990 Aug;51(8):1300-5.
    pubmed: 2386332
  6. Donawick W, Mayhew I, Galligan D, Osborne J, Green S, Stanley EK. Early diagnosis of cervical vertebral malformation in young Thoroughbred horses and successful treatment with restricted, paced diet and confinement. Proceedings of the American Association of Equine Practitioners Convention 1989; December 3 to 6; Boston, MA, USA; p. 525–528.
  7. Fayer R, Mayhew IG, Baird JD, Dill SG, Foreman JH, Fox JC, Higgins RJ, Reed SM, Ruoff WW, Sweeney RW. Epidemiology of equine protozoal myeloencephalitis in North America based on histologically confirmed cases. A report.. J Vet Intern Med 1990 Mar-Apr;4(2):54-7.
    doi: 10.1111/j.1939-1676.1990.tb03103.xpubmed: 2342022google scholar: lookup
  8. Finno CJ, Higgins RJ, Aleman M, Ofri R, Hollingsworth SR, Bannasch DL, Reilly CM, Madigan JE. Equine degenerative myeloencephalopathy in Lusitano horses.. J Vet Intern Med 2011 Nov-Dec;25(6):1439-46.
    doi: 10.1111/j.1939-1676.2011.00817.xpubmed: 22092640google scholar: lookup
  9. Finno CJ, Valberg SJ. A comparative review of vitamin E and associated equine disorders.. J Vet Intern Med 2012 Nov-Dec;26(6):1251-66.
    doi: 10.1111/j.1939-1676.2012.00994.xpubmed: 22925200google scholar: lookup
  10. Furr M, Howe D, Reed S, Yeargan M. Antibody coefficients for the diagnosis of equine protozoal myeloencephalitis.. J Vet Intern Med 2011 Jan-Feb;25(1):138-42.
    doi: 10.1111/j.1939-1676.2010.0658.xpubmed: 21155894google scholar: lookup
  11. Furr M, Kennedy T. Effects of coadministration of corn oil and ponazuril on serum and cerebrospinal fluid concentrations of ponazuril in horses.. J Vet Intern Med 2020 May;34(3):1321-1324.
    doi: 10.1111/jvim.15765pmc: PMC7255669pubmed: 32301131google scholar: lookup
  12. Furr M, Kennedy T, MacKay R, Reed S, Andrews F, Bernard B, Bain F, Byars D. Efficacy of ponazuril 15% oral paste as a treatment for equine protozoal myeloencephalitis.. Vet Ther 2001 Summer;2(3):215-22.
    pubmed: 19746664
  13. Furr M, Rowe DK. Equine protozoal myeloencephalitis. 2015; In: Furr M., and S. Reed, editors. Equine neurology. 2nd ed. Ames (IA): Wiley-Blackwell; p. 285–305.
  14. Gutierrez J, Eisenberg RL, Koval NJ, Armstrong ER, Tharappel J, Hughes CG, Tobin T. Pemoline and tetramisole 'positives' in english racehorses following levamisole administration.. Ir Vet J 2010 Aug 1;63(8):498.
    pmc: PMC4177197pubmed: 21777496doi: 10.1186/2046-0481-63-8-498google scholar: lookup
  15. Johnson AL. Update on infectious diseases affecting the equine nervous system.. Vet Clin North Am Equine Pract 2011 Dec;27(3):573-87.
    doi: 10.1016/j.cveq.2011.08.008pubmed: 22100045google scholar: lookup
  16. Johnson AL, Morrow JK, Sweeney RW. Indirect fluorescent antibody test and surface antigen ELISAs for antemortem diagnosis of equine protozoal myeloencephalitis.. J Vet Intern Med 2013 May-Jun;27(3):596-9.
    doi: 10.1111/jvim.12061pubmed: 23517480google scholar: lookup
  17. Johnson A, Reed S. Cervical vertebral stenotic myelopathy. 2015; In: Reed, S., and Furr M., editors. Equine neurology. 2nd ed. Ames (IA): Wiley-Blackwell; p. 349–367.
  18. Kronfeld DS, Meacham TN, Donoghue S. Dietary aspects of developmental orthopedic disease in young horses.. Vet Clin North Am Equine Pract 1990 Aug;6(2):451-65.
    pubmed: 2202502doi: 10.1016/s0749-0739(17)30551-5google scholar: lookup
  19. MacKay R. Equine protozoal myeloencephalitis: treatment, prognosis, and prevention. Clin. Tech. Equine Pract. 2006;5:9–16.
  20. MacKay R. Neurodegenerative disorders. 2015; In: Reed, S., and Furr M., editors. Equine neurology. 2nd ed. Ames (IA: ): Wiley-Blackwell.
  21. Olsen E, Dunkel B, Barker WH, Finding EJ, Perkins JD, Witte TH, Yates LJ, Andersen PH, Baiker K, Piercy RJ. Rater agreement on gait assessment during neurologic examination of horses.. J Vet Intern Med 2014 Mar-Apr;28(2):630-8.
    doi: 10.1111/jvim.12320pmc: PMC4857973pubmed: 24612411google scholar: lookup
  22. Oswald J, Love S, Parkin TD, Hughes KJ. Prevalence of cervical vertebral stenotic myelopathy in a population of thoroughbred horses.. Vet Rec 2010 Jan 16;166(3):82-3.
    doi: 10.1136/vr.b4781pubmed: 20081180google scholar: lookup
  23. Pusterla N, Tamez-Trevino E, White A, Vangeem J, Packham A, Conrad PA, Kass P. Comparison of prevalence factors in horses with and without seropositivity to Neospora hughesi and/or Sarcocystis neurona.. Vet J 2014 May;200(2):332-4.
    doi: 10.1016/j.tvjl.2014.03.014pubmed: 24703324google scholar: lookup
  24. Pusterla N, Tobin T. Therapeutics for Equine Protozoal Myeloencephalitis.. Vet Clin North Am Equine Pract 2017 Apr;33(1):87-97.
    doi: 10.1016/j.cveq.2016.12.001pubmed: 28161037google scholar: lookup
  25. Reed SM, Furr M, Howe DK, Johnson AL, MacKay RJ, Morrow JK, Pusterla N, Witonsky S. Equine Protozoal Myeloencephalitis: An Updated Consensus Statement with a Focus on Parasite Biology, Diagnosis, Treatment, and Prevention.. J Vet Intern Med 2016 Mar-Apr;30(2):491-502.
    doi: 10.1111/jvim.13834pmc: PMC4913613pubmed: 26857902google scholar: lookup
  26. Reed SM, Howe DK, Morrow JK, Graves A, Yeargan MR, Johnson AL, MacKay RJ, Furr M, Saville WJ, Williams NM. Accurate antemortem diagnosis of equine protozoal myeloencephalitis (EPM) based on detecting intrathecal antibodies against Sarcocystis neurona using the SnSAG2 and SnSAG4/3 ELISAs.. J Vet Intern Med 2013 Sep-Oct;27(5):1193-200.
    doi: 10.1111/jvim.12158pubmed: 24033423google scholar: lookup
  27. Saville WJA, Reed SM, Dubey JP, Granstrom DE, Morley PS, Hinchcliff KW, Kohn CW, Wittum TE, Workman JD. Interobserver Variation in the Diagnosis of Neurologic Abnormalities in the Horse.. J Vet Intern Med 2017 Nov;31(6):1871-1876.
    doi: 10.1111/jvim.14822pmc: PMC5697190pubmed: 28887894google scholar: lookup
  28. Schering-Plough Animal Health Corporation. Freedom of information summary, NADA 141–268. PROTAZIL Anti-protozoal Pellets (1.56% diclazuril) for the treatment of equine protozoal myeloencephalitis (EPM) caused by Sarcocystis neurona in horses. 2007.
  29. Van Biervliet J. An evidence-based approach to clinical questions in the practice of equine neurology.. Vet Clin North Am Equine Pract 2007 Aug;23(2):317-28.
    doi: 10.1016/j.cveq.2007.03.009pubmed: 17616316google scholar: lookup
  30. Walmsley J. Surgical treatment of cervical spinal cord compression in horses: a European experience. Equine Vet. Educ. 2005;17:39–43.
    doi: 10.1111/j.2042-3292.2005.tb00334.xgoogle scholar: lookup

Citations

This article has been cited 2 times.
  1. Journée SL, Journée HL, Bergmann W, Chantziaras I, Vanderperren K, Raes E, Reed SM, de Bruijn CM, Berends HI, Delesalle CJG. Evaluation of the diagnostic value of transcranial electrical stimulation (TES) to assess neuronal functional integrity in horses. Front Neurosci 2024;18:1342803.
    doi: 10.3389/fnins.2024.1342803pubmed: 38665290google scholar: lookup
  2. Palmisano M, Kulp J, Bender S, Stefanovski D, Robinson M, Johnson A. Measurement of 8-hydroxy-2'-deoxyguanosine in serum and cerebrospinal fluid of horses with neuroaxonal degeneration and other causes of proprioceptive ataxia. J Vet Intern Med 2024 Mar-Apr;38(2):1207-1213.
    doi: 10.1111/jvim.16988pubmed: 38205913google scholar: lookup
Subscribe to our newsletter
Join 99,383 horse owners like you who receive our email updates on horse health and nutrition.